ProCE Banner Activity

ExpressPoints: Application of Existing and Emerging Biomarkers for Immuno-Oncology Across Tumor Types

Slideset Download
Download this short summary slideset of key takeaways from a live CCO Webinar on the use of biomarkers to identify patients who may benefit from immune checkpoint therapy across various solid tumors.

Released: July 15, 2020

Expiration: July 14, 2021

No longer available for credit.

Share

Faculty

John P. Leonard

John P. Leonard, MD

Chief, Lymphoma/Myeloma Service
Division of Hematology and Oncology
Weill Medical College of Cornell University
New York Presbyterian Hospital
New York Weill Cornell Center
New York, New York

Jamie E. Chaft

Jamie E. Chaft, MD

Associate Attending Physician
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York

Scot Niglio

Scot Niglio, MD

Medical Oncologist
Bethesda, Maryland

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Merck Sharp & Dohme Corp.

Program Director Disclosure

Program Director

John P. Leonard, MD

Chief, Lymphoma/Myeloma Service
Division of Hematology and Oncology
Weill Medical College of Cornell University
New York Presbyterian Hospital
New York Weill Cornell Center
New York, New York

Faculty Disclosure

Primary Author

Jamie E. Chaft, MD

Associate Attending Physician
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York

Scot Niglio, MD

Medical Oncologist
Bethesda, Maryland